These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18617621)

  • 21. Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support.
    Schwientek P; Ellinghaus P; Steppan S; D'Urso D; Seewald M; Kassner A; Cebulla R; Schulte-Eistrup S; Morshuis M; Röfe D; El Banayosy A; Körfer R; Milting H
    Physiol Genomics; 2010 Aug; 42(3):397-405. PubMed ID: 20460602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrin expression during reverse remodeling in the myocardium of heart failure patients.
    Dullens HF; Schipper ME; van Kuik J; Sohns W; Scheenstra M; van Wichen DF; Van Oosterhout MF; de Jonge N; de Weger RA
    Cardiovasc Pathol; 2012; 21(4):291-8. PubMed ID: 22100988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.
    Maruyama S; Nakamura K; Papanicolaou KN; Sano S; Shimizu I; Asaumi Y; van den Hoff MJ; Ouchi N; Recchia FA; Walsh K
    EMBO Mol Med; 2016 Aug; 8(8):949-66. PubMed ID: 27234440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follistatin-like 1 in vertebrate development.
    Sylva M; Moorman AF; van den Hoff MJ
    Birth Defects Res C Embryo Today; 2013 Mar; 99(1):61-9. PubMed ID: 23723173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.
    Oshima Y; Ouchi N; Shimano M; Pimentel DR; Papanicolaou KN; Panse KD; Tsuchida K; Lara-Pezzi E; Lee SJ; Walsh K
    Circulation; 2009 Oct; 120(16):1606-15. PubMed ID: 19805648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
    Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
    FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activin type II receptor signaling in cardiac aging and heart failure.
    Roh JD; Hobson R; Chaudhari V; Quintero P; Yeri A; Benson M; Xiao C; Zlotoff D; Bezzerides V; Houstis N; Platt C; Damilano F; Lindman BR; Elmariah S; Biersmith M; Lee SJ; Seidman CE; Seidman JG; Gerszten RE; Lach-Trifilieff E; Glass DJ; Rosenzweig A
    Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome.
    Widera C; Giannitsis E; Kempf T; Korf-Klingebiel M; Fiedler B; Sharma S; Katus HA; Asaumi Y; Shimano M; Walsh K; Wollert KC
    Clin Chem; 2012 Aug; 58(8):1233-41. PubMed ID: 22675198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts.
    Uchinaka A; Kawaguchi N; Hamada Y; Mori S; Miyagawa S; Saito A; Sawa Y; Matsuura N
    Cardiovasc Res; 2013 Jul; 99(1):102-10. PubMed ID: 23615564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
    Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
    J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of expression of the Follistatin and Follistatin-like1 genes during chicken heart development: a potential role in valvulogenesis and late heart muscle cell formation.
    van den Berg G; Somi S; Buffing AA; Moorman AF; van den Hoff MJ
    Anat Rec (Hoboken); 2007 Jul; 290(7):783-7. PubMed ID: 17549728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
    Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
    Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells.
    Görgens SW; Raschke S; Holven KB; Jensen J; Eckardt K; Eckel J
    Arch Physiol Biochem; 2013 May; 119(2):75-80. PubMed ID: 23419164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detrimental effect of fractalkine on myocardial ischaemia and heart failure.
    Xuan W; Liao Y; Chen B; Huang Q; Xu D; Liu Y; Bin J; Kitakaze M
    Cardiovasc Res; 2011 Dec; 92(3):385-93. PubMed ID: 21840883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium.
    Oliveira GH; Brann CN; Becker K; Thohan V; Koerner MM; Loebe M; Noon GP; Torre-Amione G
    Am J Cardiol; 2006 Jun; 97(11):1626-9. PubMed ID: 16728227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of genes related to heart failure using global gene expression profiling of human failing myocardium.
    Min KD; Asakura M; Liao Y; Nakamaru K; Okazaki H; Takahashi T; Fujimoto K; Ito S; Takahashi A; Asanuma H; Yamazaki S; Minamino T; Sanada S; Seguchi O; Nakano A; Ando Y; Otsuka T; Furukawa H; Isomura T; Takashima S; Mochizuki N; Kitakaze M
    Biochem Biophys Res Commun; 2010 Feb; 393(1):55-60. PubMed ID: 20100464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell type specific expression of Follistatin-like 1 (Fstl1) in mouse embryonic lung development.
    Liu X; Liu Y; Yang Z; Ning W
    J Mol Histol; 2018 Aug; 49(4):399-409. PubMed ID: 29916090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered long noncoding RNA expression profiles in the myocardium of rats with ischemic heart failure.
    Gao W; Wang ZM; Zhu M; Lian XQ; Zhao H; Zhao D; Yang ZJ; Lu X; Wang LS
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):473-9. PubMed ID: 26002832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.